© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Washington - The FDA advisory panel reviewing Hylaform and Restylane, the newest upstarts in the battle against wrinkles and scars, recommended each for approval, with conditions, by a 6-3 vote November 21.